B. Riley Wealth Management’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

B. Riley Wealth Management’s Portfolio ARDS Stock Details ARDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$11	Buy	+10,000	New	+$12.4K	﹤0.01%	751

Other funds holding ARDS

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MWM

Minot Wealth Management Westwood, Massachusetts $389M AUM 3.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

B. Riley Wealth Management's ARDS Position: Q2 2022 in Review

B. Riley Wealth Management opened a new position in Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q2 2022: 10,000 shares worth $11. The stake represents ﹤0.01% of the portfolio and ranks #751 among its holdings.

19 funds tracked by Wall St. Rank hold ARDS as of Q2 2022.

B. Riley Wealth Management held 10,000 shares of Aridis Pharmaceuticals Inc. Common Stock worth $11 as of Q2 2022.
Aridis Pharmaceuticals Inc. Common Stock was a new B. Riley Wealth Management position in Q2 2022.
Aridis Pharmaceuticals Inc. Common Stock made up ﹤0.01% of B. Riley Wealth Management's portfolio in Q2 2022, its #751 holding.
19 funds tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q2 2022.

Based on B. Riley Wealth Management's 13F filing for Q2 2022, filed 9 Sep 2022.